178 related articles for article (PubMed ID: 35182475)
61. In the aftermath of clozapine discontinuation: comparative effectiveness and safety of antipsychotics in patients with schizophrenia who discontinue clozapine.
Luykx JJ; Stam N; Tanskanen A; Tiihonen J; Taipale H
Br J Psychiatry; 2020 Sep; 217(3):498-505. PubMed ID: 31910911
[TBL] [Abstract][Full Text] [Related]
62. Cost of relapse in schizophrenia.
Weiden PJ; Olfson M
Schizophr Bull; 1995; 21(3):419-29. PubMed ID: 7481573
[TBL] [Abstract][Full Text] [Related]
63. Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials.
Tani H; Takasu S; Uchida H; Suzuki T; Mimura M; Takeuchi H
Neuropsychopharmacology; 2020 Apr; 45(5):887-901. PubMed ID: 31770770
[TBL] [Abstract][Full Text] [Related]
64. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
65. Endogenous and Antipsychotic-Related Risks for Diabetes Mellitus in Young People With Schizophrenia: A Danish Population-Based Cohort Study.
Rajkumar AP; Horsdal HT; Wimberley T; Cohen D; Mors O; Børglum AD; Gasse C
Am J Psychiatry; 2017 Jul; 174(7):686-694. PubMed ID: 28103712
[TBL] [Abstract][Full Text] [Related]
66. Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis.
Moisan J; Grégoire JP
Clin Ther; 2010; 32 Suppl 1():S21-31. PubMed ID: 20152549
[TBL] [Abstract][Full Text] [Related]
67. Cognitive Behavioural Therapy for Psychosis: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2018; 18(5):1-141. PubMed ID: 30443277
[TBL] [Abstract][Full Text] [Related]
68. Relapse rates in patients with schizophrenia receiving aripiprazole in comparison with other atypical antipsychotics.
Moeller KE; Shireman TI; Liskow BI
J Clin Psychiatry; 2006 Dec; 67(12):1942-7. PubMed ID: 17194273
[TBL] [Abstract][Full Text] [Related]
69. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B
J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992
[TBL] [Abstract][Full Text] [Related]
70. Cost-effectiveness analysis of switching antipsychotic medication to long-acting injectable risperidone in patients with schizophrenia : a 12- and 24-month follow-up from the e-STAR database in Spain.
Olivares JM; Rodriguez-Martinez A; Burón JA; Alonso-Escolano D; Rodriguez-Morales A;
Appl Health Econ Health Policy; 2008; 6(1):41-53. PubMed ID: 18774869
[TBL] [Abstract][Full Text] [Related]
71. Long-term antipsychotic use and its association with outcomes in schizophrenia - the Northern Finland Birth Cohort 1966.
Moilanen JM; Haapea M; Jääskeläinen E; Veijola JM; Isohanni MK; Koponen HJ; Miettunen J
Eur Psychiatry; 2016 Aug; 36():7-14. PubMed ID: 27311102
[TBL] [Abstract][Full Text] [Related]
72. Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study.
Kroken RA; Johnsen E; Ruud T; Wentzel-Larsen T; Jørgensen HA
BMC Psychiatry; 2009 May; 9():24. PubMed ID: 19445700
[TBL] [Abstract][Full Text] [Related]
73. Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis.
Alvarez-Jiménez M; Parker AG; Hetrick SE; McGorry PD; Gleeson JF
Schizophr Bull; 2011 May; 37(3):619-30. PubMed ID: 19900962
[TBL] [Abstract][Full Text] [Related]
74. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
[TBL] [Abstract][Full Text] [Related]
75. Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based "Real-World" Study.
Zhang C; Chen MJ; Wu GJ; Wang ZW; Rao SZ; Zhang Y; Yi ZH; Yang WM; Gao KM; Song LS
J Clin Psychiatry; 2016 Nov; 77(11):e1460-e1466. PubMed ID: 28076667
[TBL] [Abstract][Full Text] [Related]
76. The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics.
De Hert M; Sermon J; Geerts P; Vansteelandt K; Peuskens J; Detraux J
CNS Drugs; 2015 Aug; 29(8):637-58. PubMed ID: 26293744
[TBL] [Abstract][Full Text] [Related]
77. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.
Kahn RS; Fleischhacker WW; Boter H; Davidson M; Vergouwe Y; Keet IP; Gheorghe MD; Rybakowski JK; Galderisi S; Libiger J; Hummer M; Dollfus S; López-Ibor JJ; Hranov LG; Gaebel W; Peuskens J; Lindefors N; Riecher-Rössler A; Grobbee DE;
Lancet; 2008 Mar; 371(9618):1085-97. PubMed ID: 18374841
[TBL] [Abstract][Full Text] [Related]
78. Survival analysis of the use of first and second generation antipsychotics among patients suffering schizophrenia: A nationwide population-based cohort study.
Chen VC; Liao YT; Lai TJ; Lane HY; Shao WC; Dewey M; Lee CT; Lu ML
Schizophr Res; 2015 Dec; 169(1-3):406-411. PubMed ID: 26481616
[TBL] [Abstract][Full Text] [Related]
79. Correlates of rehospitalisation in schizophrenia.
Dey S; Menkes DB; Obertova Z; Chaudhuri S; Mellsop G
Australas Psychiatry; 2016 Aug; 24(4):356-9. PubMed ID: 26906441
[TBL] [Abstract][Full Text] [Related]
80. Antipsychotics and mortality in first-onset schizophrenia: prospective Finnish register study with 5-year follow-up.
Kiviniemi M; Suvisaari J; Koivumaa-Honkanen H; Häkkinen U; Isohanni M; Hakko H
Schizophr Res; 2013 Oct; 150(1):274-80. PubMed ID: 23953217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]